Exponent, Inc. (NASDAQ:EXPO – Get Free Report) insider Eric Guyer sold 1,650 shares of the stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $92.58, for a total value of $152,757.00. Following the transaction, the insider now directly owns 1,846 shares of the company’s stock, valued at $170,902.68. The sale was disclosed in a filing with the SEC, which is available at this link.
Eric Guyer also recently made the following trade(s):
- On Friday, February 9th, Eric Guyer sold 3,367 shares of Exponent stock. The stock was sold at an average price of $78.49, for a total value of $264,275.83.
Exponent Stock Down 1.4 %
NASDAQ EXPO traded down $1.29 during mid-day trading on Tuesday, hitting $91.91. The stock had a trading volume of 494,534 shares, compared to its average volume of 317,267. Exponent, Inc. has a 52-week low of $64.61 and a 52-week high of $102.72. The company has a market cap of $4.66 billion, a price-to-earnings ratio of 46.42 and a beta of 0.68. The company has a 50 day simple moving average of $80.23 and a 200 day simple moving average of $81.85.
Exponent Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 21st. Investors of record on Friday, June 7th will be paid a $0.28 dividend. This represents a $1.12 annualized dividend and a yield of 1.22%. The ex-dividend date is Friday, June 7th. Exponent’s payout ratio is currently 56.57%.
Analyst Ratings Changes
EXPO has been the subject of a number of analyst reports. StockNews.com raised Exponent from a “sell” rating to a “hold” rating in a research note on Monday, March 4th. Truist Financial increased their target price on Exponent from $95.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday.
Check Out Our Latest Stock Analysis on Exponent
Hedge Funds Weigh In On Exponent
Several hedge funds have recently bought and sold shares of EXPO. Operose Advisors LLC acquired a new stake in Exponent during the 3rd quarter valued at $39,000. Benjamin F. Edwards & Company Inc. grew its holdings in Exponent by 866.0% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 512 shares of the business services provider’s stock valued at $42,000 after buying an additional 459 shares during the last quarter. Janiczek Wealth Management LLC grew its holdings in Exponent by 293.7% during the 1st quarter. Janiczek Wealth Management LLC now owns 626 shares of the business services provider’s stock valued at $52,000 after buying an additional 467 shares during the last quarter. Principal Securities Inc. acquired a new stake in Exponent during the 4th quarter valued at $69,000. Finally, YHB Investment Advisors Inc. acquired a new stake in Exponent during the 1st quarter valued at $75,000. 92.37% of the stock is owned by hedge funds and other institutional investors.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also
- Five stocks we like better than Exponent
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- With Risk Tolerance, One Size Does Not Fit All
- Hilton Demonstrates Asset Light is Right for Investors
- What Makes a Stock a Good Dividend Stock?
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.